Bayer MaterialScience AG has invested EUR 2.3 mln in a new production line for its Baycusan® range of waterborne polyurethane dispersions (PUD) for the cosmetics and medical segments. The new facility, which forms part of the PUD plant at the Dormagen CHEMPARK, will produce special, top-quality polyurethane dispersions of maximum purity, which will be sold to the cosmetics industry under the name Baycusan® C. The dispersions do not contain any kind of co-solvent, are free of preservatives and thus have characteristics that are unique to this market.
The Dormagen facility is already preparing for the next stage. As the product also conforms to the requirements made on polyurethane dispersions for medical applications, Bayer MaterialScience is also currently preparing to launch a Baycusan® product line into the medical market.
05-Jun-09 
{{comment.DateTimeStampDisplay}}
{{comment.Comments}}